Clinical Trial Search Results for "JUMBO-TIMI 26"

Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., Braunwald, E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation. 2005;111(25):3366-73.

Bonaca, M. P., Wiviott, S. D., Sabatine, M. S., Buros, J., Murphy, S. A., Scirica, B. M., Rifai, N., Antman, E. M., Morrow, D. A. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial) Am J Cardiol. 2007;99(3):344-8.